Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia: data from a multicenter registry
Background - Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. - Methods and Results - In total, 1596 consecutive patients were included in a mult...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 September 2023
|
| In: |
Journal of the American Heart Association
Year: 2023, Jahrgang: 12, Heft: 18, Pages: 1-8 |
| ISSN: | 2047-9980 |
| DOI: | 10.1161/JAHA.123.030615 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1161/JAHA.123.030615 Verlag, kostenfrei, Volltext: https://www.ahajournals.org/doi/10.1161/JAHA.123.030615 
|
| Verfasserangaben: | Ibrahim El‐Battrawy, MD; Katharina Koepsel; David Tenbrink; Boldizsar Kovacs, MD, MSc; Tobias C. Dreher; Christian Blockhaus, MD; Michael Gotzmann, MD; Norbert Klein, MD; Thomas Kuntz, MD; Dong‐In Shin, MD; Hendrik Lapp, MD; Stephanie Rosenkaimer, MD; Mohammad Abumayyaleh, MD; Nazha Hamdani, PhD; Ardan Muammer Saguner, MD; Jacqueline Kowitz; Julia W. Erath, MD; Firat Duru, MD; Andreas Mügge, MD, PhD; Ibrahim Akin, MD, PhD; Assem Aweimer, MD; Thomas Beiert, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1898169780 | ||
| 003 | DE-627 | ||
| 005 | 20241205161430.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240808s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/JAHA.123.030615 |2 doi | |
| 035 | |a (DE-627)1898169780 | ||
| 035 | |a (DE-599)KXP1898169780 | ||
| 035 | |a (OCoLC)1475306656 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a El-Battrawy, Ibrahim |d 1987- |e VerfasserIn |0 (DE-588)1033436917 |0 (DE-627)741219549 |0 (DE-576)38084673X |4 aut | |
| 245 | 1 | 0 | |a Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia |b data from a multicenter registry |c Ibrahim El‐Battrawy, MD; Katharina Koepsel; David Tenbrink; Boldizsar Kovacs, MD, MSc; Tobias C. Dreher; Christian Blockhaus, MD; Michael Gotzmann, MD; Norbert Klein, MD; Thomas Kuntz, MD; Dong‐In Shin, MD; Hendrik Lapp, MD; Stephanie Rosenkaimer, MD; Mohammad Abumayyaleh, MD; Nazha Hamdani, PhD; Ardan Muammer Saguner, MD; Jacqueline Kowitz; Julia W. Erath, MD; Firat Duru, MD; Andreas Mügge, MD, PhD; Ibrahim Akin, MD, PhD; Assem Aweimer, MD; Thomas Beiert, MD |
| 264 | 1 | |c 19 September 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 8. September 2023 | ||
| 500 | |a Gesehen am 08.08.2024 | ||
| 520 | |a Background - Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. - Methods and Results - In total, 1596 consecutive patients were included in a multicenter registry from 8 European centers, with 124 patients (8%) having received the WCD due to myocarditis and reduced left ventricular ejection fraction or prior ventricular tachyarrhythmia. The mean age was 51.6±16.3 years, with 74% being male. Patients were discharged after index hospitalization on heart failure medication: Angiotensin‐converting enzyme inhibitors (62.5%), angiotensin‐receptor‐neprilysin inhibitor (22.9%), aldosterone‐antagonists (51%), or beta blockers (91.4%). The initial median left ventricular ejection fraction was 30% (22%-45%) and increased to 48% (39%-55%) over long‐term follow‐up (P<0.001). The median BNP (brain natriuretic peptide) level at baseline was 1702 pg/mL (565-3748) and decreased to 188 pg/mL (26-348) over long‐term follow‐up (P=0.022). The mean wear time was 79.7±52.1 days and 21.0±4.9 hours per day. Arrhythmic event rates documented by the WCD were 9.7% for nonsustained ventricular tachycardia, 6.5% for sustained ventricular tachycardia, and 0% for ventricular fibrillation. Subsequently, 2.4% of patients experienced an appropriate WCD shock. The rate of inappropriate WCD shocks was 0.8%. All 3 patients with appropriate WCD shock had experienced ventricular tachycardia/ventricular fibrillation before WCD prescription, with only 1 patient showing a left ventricular ejection fraction <35%. - Conclusions - Patients with myocarditis and risk for occurrence of ventricular tachyarrhythmia may benefit from WCD use. Prior ventricular arrhythmia might appear as a better risk predictor than a reduced left ventricular ejection fraction <35% in this population. | ||
| 700 | 1 | |a Koepsel, Katharina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tenbrink, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kovacs, Boldizsar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreher, Tobias C. |d 1989- |e VerfasserIn |0 (DE-588)1294773291 |0 (DE-627)1851408304 |4 aut | |
| 700 | 1 | |a Blockhaus, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gotzmann, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klein, Norbert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kuntz, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Shin, Dong‐In |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lapp, Hendrik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rosenkaimer, Stephanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Abumayyaleh, Mohammad S. A. |d 1990- |e VerfasserIn |0 (DE-588)1215107617 |0 (DE-627)172611743X |4 aut | |
| 700 | 1 | |a Hamdani, Nazha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Saguner, Ardan Muammer |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kowitz, Jacqueline |e VerfasserIn |4 aut | |
| 700 | 1 | |a Erath, Julia W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Duru, Firat |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mügge, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Akın, Ibrahim |d 1978- |e VerfasserIn |0 (DE-588)132322293 |0 (DE-627)521039010 |0 (DE-576)299074366 |4 aut | |
| 700 | 1 | |a Aweimer, Assem |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beiert, Thomas |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Heart Association |t Journal of the American Heart Association |d New York, NY : Association, 2012 |g 12(2023), 18, Artikel-ID e030615, Seite 1-8 |h Online-Ressource |w (DE-627)688605427 |w (DE-600)2653953-6 |w (DE-576)361844719 |x 2047-9980 |7 nnas |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:18 |g elocationid:e030615 |g pages:1-8 |g extent:8 |a Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia data from a multicenter registry |
| 856 | 4 | 0 | |u https://doi.org/10.1161/JAHA.123.030615 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.ahajournals.org/doi/10.1161/JAHA.123.030615 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240808 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 132322293 |a Akın, Ibrahim |m 132322293:Akın, Ibrahim |d 60000 |d 61000 |d 60000 |e 60000PA132322293 |e 61000PA132322293 |e 60000PA132322293 |k 0/60000/ |k 1/60000/61000/ |k 0/60000/ |p 20 | ||
| 998 | |g 1215107617 |a Abumayyaleh, Mohammad S. A. |m 1215107617:Abumayyaleh, Mohammad S. A. |d 60000 |d 61000 |e 60000PA1215107617 |e 61000PA1215107617 |k 0/60000/ |k 1/60000/61000/ |p 12 | ||
| 998 | |g 1294773291 |a Dreher, Tobias C. |m 1294773291:Dreher, Tobias C. |d 60000 |e 60000PD1294773291 |k 0/60000/ |p 4 | ||
| 998 | |g 1033436917 |a El-Battrawy, Ibrahim |m 1033436917:El-Battrawy, Ibrahim |d 60000 |d 61000 |e 60000PE1033436917 |e 61000PE1033436917 |k 0/60000/ |k 1/60000/61000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1898169780 |e 4563820067 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1898169780","physDesc":[{"noteIll":"Illustrationen","extent":"8 S."}],"title":[{"subtitle":"data from a multicenter registry","title":"Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia","title_sort":"Use of the wearable cardioverter‐defibrillator among patients with myocarditis and reduced ejection fraction or ventricular tachyarrhythmia"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Online veröffentlicht: 8. September 2023","Gesehen am 08.08.2024"],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"19 September 2023"}],"person":[{"display":"El-Battrawy, Ibrahim","role":"aut","given":"Ibrahim","family":"El-Battrawy"},{"role":"aut","given":"Katharina","family":"Koepsel","display":"Koepsel, Katharina"},{"display":"Tenbrink, David","family":"Tenbrink","role":"aut","given":"David"},{"display":"Kovacs, Boldizsar","family":"Kovacs","given":"Boldizsar","role":"aut"},{"display":"Dreher, Tobias C.","given":"Tobias C.","role":"aut","family":"Dreher"},{"display":"Blockhaus, Christian","role":"aut","given":"Christian","family":"Blockhaus"},{"display":"Gotzmann, Michael","given":"Michael","role":"aut","family":"Gotzmann"},{"display":"Klein, Norbert","given":"Norbert","role":"aut","family":"Klein"},{"display":"Kuntz, Thomas","role":"aut","given":"Thomas","family":"Kuntz"},{"given":"Dong‐In","role":"aut","family":"Shin","display":"Shin, Dong‐In"},{"family":"Lapp","given":"Hendrik","role":"aut","display":"Lapp, Hendrik"},{"family":"Rosenkaimer","role":"aut","given":"Stephanie","display":"Rosenkaimer, Stephanie"},{"family":"Abumayyaleh","given":"Mohammad S. A.","role":"aut","display":"Abumayyaleh, Mohammad S. A."},{"display":"Hamdani, Nazha","family":"Hamdani","role":"aut","given":"Nazha"},{"display":"Saguner, Ardan Muammer","role":"aut","given":"Ardan Muammer","family":"Saguner"},{"display":"Kowitz, Jacqueline","family":"Kowitz","role":"aut","given":"Jacqueline"},{"role":"aut","given":"Julia W.","family":"Erath","display":"Erath, Julia W."},{"display":"Duru, Firat","role":"aut","given":"Firat","family":"Duru"},{"display":"Mügge, Andreas","family":"Mügge","given":"Andreas","role":"aut"},{"family":"Akın","role":"aut","given":"Ibrahim","display":"Akın, Ibrahim"},{"family":"Aweimer","role":"aut","given":"Assem","display":"Aweimer, Assem"},{"display":"Beiert, Thomas","role":"aut","given":"Thomas","family":"Beiert"}],"relHost":[{"title":[{"subtitle":"JAHA","title":"Journal of the American Heart Association","title_sort":"Journal of the American Heart Association"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 09.01.14"],"origin":[{"publisher":"Association","dateIssuedKey":"2012","publisherPlace":"New York, NY","dateIssuedDisp":"2012-"}],"disp":"American Heart AssociationJournal of the American Heart Association","recId":"688605427","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["688605427"],"issn":["2047-9980"],"zdb":["2653953-6"]},"part":{"pages":"1-8","extent":"8","text":"12(2023), 18, Artikel-ID e030615, Seite 1-8","issue":"18","year":"2023","volume":"12"},"titleAlt":[{"title":"Journal of the American Heart Association, Cardiovascular and Cerebrovascular Disease"},{"title":"JAHA"}],"pubHistory":["1.2012 -"],"corporate":[{"role":"aut","display":"American Heart Association"}]}],"id":{"eki":["1898169780"],"doi":["10.1161/JAHA.123.030615"]},"name":{"displayForm":["Ibrahim El‐Battrawy, MD; Katharina Koepsel; David Tenbrink; Boldizsar Kovacs, MD, MSc; Tobias C. Dreher; Christian Blockhaus, MD; Michael Gotzmann, MD; Norbert Klein, MD; Thomas Kuntz, MD; Dong‐In Shin, MD; Hendrik Lapp, MD; Stephanie Rosenkaimer, MD; Mohammad Abumayyaleh, MD; Nazha Hamdani, PhD; Ardan Muammer Saguner, MD; Jacqueline Kowitz; Julia W. Erath, MD; Firat Duru, MD; Andreas Mügge, MD, PhD; Ibrahim Akin, MD, PhD; Assem Aweimer, MD; Thomas Beiert, MD"]}} | ||
| SRT | |a ELBATTRAWYUSEOFTHEWE1920 | ||